{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:15Z","timestamp":1787003595828,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T00:00:00Z","timestamp":1609113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T00:00:00Z","timestamp":1609113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["#2018-02532"],"award-info":[{"award-number":["#2018-02532"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["#2017-00915"],"award-info":[{"award-number":["#2017-00915"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["#681712"],"award-info":[{"award-number":["#681712"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish government and the County Councils, the ALF agreement","award":["#ALFGBG-720931"],"award-info":[{"award-number":["#ALFGBG-720931"]}]},{"name":"Swedish government and the County Councils, the ALF agreement","award":["#ALFGBG-715986"],"award-info":[{"award-number":["#ALFGBG-715986"]}]},{"name":"Swedish government and the County Councils, the ALF agreement","award":["ALFGBG-588341"],"award-info":[{"award-number":["ALFGBG-588341"]}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["#201809-2016682"],"award-info":[{"award-number":["#201809-2016682"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["No 860197"],"award-info":[{"award-number":["No 860197"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Alzheimer foundation","award":["#AF-742881"],"award-info":[{"award-number":["#AF-742881"]}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["#FO2017-0243"],"award-info":[{"award-number":["#FO2017-0243"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Torsten S\u00f6derberg Professorship in Medicine ate the Royal Swedish Academy of Sciences"},{"name":"Gothenburg University Library"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Varicella-zoster virus (VZV) is one of the most common agents causing viral infections of the central nervous system (CNS). VZV encephalitis is associated with severe neurological sequelae, despite antiviral treatment. Cognitive impairment has been reported and VZV has been associated with dementia. Our aim was to investigate the cognitive impairment and cerebrospinal fluid biomarkers in a follow-up study of patients with VZV encephalitis. Thirteen patients with VZV encephalitis, diagnosed by detection of VZV DNA in cerebrospinal fluid (CSF) by PCR and concomitant symptoms of encephalitis, were included. Neuropsychological assessment in parallel with a lumbar puncture to obtain CSF was performed 1.5\u20137\u00a0years after acute disease. The CSF biomarkers neurofilament light chain (NFL), S100B, glial fibrillary acidic protein (GFAP), amyloid-\u03b2 (A\u03b2) 40 and A\u03b242, total tau (t-tau) and phosphorylated tau (p-tau) were analysed and compared to controls (n\u2009=\u200924). Cognitive impairment was shown in the domains of executive functions and speed\/attention and to a minor degree in the domains of learning\/memory and language, indicated by a significantly poorer performance on seven neuropsychological test variables. No convincing evidence of alterations in concentrations of biomarkers in the CSF were shown. Our results indicate that patients with VZV encephalitis suffer from cognitive impairment long time after acute disease. Importantly, these impairments do not seem to be accompanied by biomarker evidence of ongoing neuronal or astrocytic injury\/activation or induction of dementia-related brain pathologies by the infection.<\/jats:p>","DOI":"10.1038\/s41598-020-79800-2","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T06:02:37Z","timestamp":1609135357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study"],"prefix":"10.1038","volume":"10","author":[{"given":"Marie","family":"Eckerstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Grahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,28]]},"reference":[{"key":"79800_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jcv.2009.07.014","volume":"46","author":"A Persson","year":"2009","unstructured":"Persson, A., Bergstrom, T., Lindh, M., Namvar, L. & Studahl, M. Varicella-zoster virus CNS disease\u2013viral load, clinical manifestations and sequels. J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol. 46, 249\u2013253. https:\/\/doi.org\/10.1016\/j.jcv.2009.07.014 (2009).","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"79800_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-7057-1","author":"A Grahn","year":"2013","unstructured":"Grahn, A., Nilsson, S., Nordlund, A., Linden, T. & Studahl, M. Cognitive impairment 3 years after neurological Varicella-zoster virus infection: a long-term case control study. J. Neurol. https:\/\/doi.org\/10.1007\/s00415-013-7057-1 (2013).","journal-title":"J. Neurol."},{"key":"79800_CR3","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/cid\/cis226","volume":"54","author":"A Mailles","year":"2012","unstructured":"Mailles, A. et al. Long-term outcome of patients presenting with acute infectious encephalitis of various causes in France. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 54, 1455\u20131464. https:\/\/doi.org\/10.1093\/cid\/cis226 (2012).","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"79800_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","volume":"10","author":"J Granerod","year":"2010","unstructured":"Granerod, J. et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet. Infect. Dis 10, 835\u2013844. https:\/\/doi.org\/10.1016\/S1473-3099(10)70222-X (2010).","journal-title":"Lancet. Infect. Dis"},{"key":"79800_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s004150050078","volume":"244","author":"L Hokkanen","year":"1997","unstructured":"Hokkanen, L. et al. Subcortical type cognitive impairment in herpes zoster encephalitis. J. Neurol. 244, 239\u2013245 (1997).","journal-title":"J. Neurol."},{"key":"79800_CR6","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1007\/s00415-002-0874-2","volume":"249","author":"K Wetzel","year":"2002","unstructured":"Wetzel, K. et al. Good cognitive outcome of patients with herpes zoster encephalitis: a follow-up study. J. Neurol. 249, 1612\u20131614 (2002).","journal-title":"J. Neurol."},{"key":"79800_CR7","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s00415-013-7057-1","volume":"260","author":"A Grahn","year":"2013","unstructured":"Grahn, A., Nilsson, S., Nordlund, A., Linden, T. & Studahl, M. Cognitive impairment 3 years after neurological Varicella-zoster virus infection: a long-term case control study. J. Neurol. 260, 2761\u20132769. https:\/\/doi.org\/10.1007\/s00415-013-7057-1 (2013).","journal-title":"J. Neurol."},{"key":"79800_CR8","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.16m11312","author":"VC Chen","year":"2018","unstructured":"Chen, V. C. et al. Herpes zoster and dementia: a nationwide population-based cohort study. J. Clin. Psychiatry https:\/\/doi.org\/10.4088\/JCP.16m11312 (2018).","journal-title":"J. Clin. Psychiatry"},{"key":"79800_CR9","doi-asserted-by":"publisher","first-page":"e0188490","DOI":"10.1371\/journal.pone.0188490","volume":"12","author":"MC Tsai","year":"2017","unstructured":"Tsai, M. C. et al. Increased risk of dementia following herpes zoster ophthalmicus. PLoS ONE 12, e0188490. https:\/\/doi.org\/10.1371\/journal.pone.0188490 (2017).","journal-title":"PLoS ONE"},{"key":"79800_CR10","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s00415-013-6883-5","volume":"260","author":"A Grahn","year":"2013","unstructured":"Grahn, A. et al. Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections. J. Neurol. 260, 1813\u20131821. https:\/\/doi.org\/10.1007\/s00415-013-6883-5 (2013).","journal-title":"J. Neurol."},{"key":"79800_CR11","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1111\/ejn.13403","volume":"44","author":"J Lindstrom","year":"2016","unstructured":"Lindstrom, J., Grahn, A., Zetterberg, H. & Studahl, M. Cerebrospinal fluid viral load and biomarkers of neuronal and glial cells in Ramsay Hunt syndrome. Eur. J. Neurosci. 44, 2944\u20132949. https:\/\/doi.org\/10.1111\/ejn.13403 (2016).","journal-title":"Eur. J. Neurosci."},{"key":"79800_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","volume":"284","author":"K Blennow","year":"2018","unstructured":"Blennow, K. & Zetterberg, H. Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future. J. Intern. Med. 284, 643\u2013663. https:\/\/doi.org\/10.1111\/joim.12816 (2018).","journal-title":"J. Intern. Med."},{"key":"79800_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz560","author":"AN Bubak","year":"2019","unstructured":"Bubak, A. N. et al. Varicella zoster virus infection of primary human spinal astrocytes produces intracellular amylin, amyloid-beta, and an amyloidogenic extracellular environment. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiz560 (2019).","journal-title":"J. Infect. Dis."},{"key":"79800_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2377-9-63","volume":"9","author":"M Gisslen","year":"2009","unstructured":"Gisslen, M. et al. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol. 9, 63. https:\/\/doi.org\/10.1186\/1471-2377-9-63 (2009).","journal-title":"BMC Neurol."},{"key":"79800_CR15","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s00415-012-6688-y","volume":"260","author":"JJ Krut","year":"2013","unstructured":"Krut, J. J. et al. Cerebrospinal fluid Alzheimer\u2019s biomarker profiles in CNS infections. J. Neurol. 260, 620\u2013626. https:\/\/doi.org\/10.1007\/s00415-012-6688-y (2013).","journal-title":"J. Neurol."},{"key":"79800_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.01.013","volume":"53","author":"PJ Nathan","year":"2017","unstructured":"Nathan, P. J. et al. Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI). Neurobiol. Aging 53, 1\u201310. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.01.013 (2017).","journal-title":"Neurobiol. Aging"},{"key":"79800_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s11682-012-9177-0","volume":"6","author":"SD Han","year":"2012","unstructured":"Han, S. D. et al. Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer\u2019s Disease. Brain Imaging Behav. 6, 610\u2013620. https:\/\/doi.org\/10.1007\/s11682-012-9177-0 (2012).","journal-title":"Brain Imaging Behav."},{"key":"79800_CR18","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1007\/s00415-019-09398-7","volume":"266","author":"L Gaetani","year":"2019","unstructured":"Gaetani, L. et al. Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis. J. Neurol. 266, 2157\u20132163. https:\/\/doi.org\/10.1007\/s00415-019-09398-7 (2019).","journal-title":"J. Neurol."},{"key":"79800_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13195-018-0339-1","volume":"10","author":"L Gaetani","year":"2018","unstructured":"Gaetani, L. et al. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation. Alzheimer\u2019s Res. Ther. 10, 8. https:\/\/doi.org\/10.1186\/s13195-018-0339-1 (2018).","journal-title":"Alzheimer's Res. Ther."},{"key":"79800_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0165-0270(92)90004-w","volume":"44","author":"LE Rosengren","year":"1992","unstructured":"Rosengren, L. E. et al. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children. J. Neurosci. Methods 44, 113\u2013119. https:\/\/doi.org\/10.1016\/0165-0270(92)90004-w (1992).","journal-title":"J. Neurosci. Methods"},{"key":"79800_CR21","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1002\/acn3.50873","volume":"6","author":"D Alcolea","year":"2019","unstructured":"Alcolea, D. et al. Agreement of amyloid PET and CSF biomarkers for Alzheimer\u2019s disease on Lumipulse. Ann. Clin. Transl. Neurol. 6, 1815\u20131824. https:\/\/doi.org\/10.1002\/acn3.50873 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"79800_CR22","first-page":"169","volume":"6","author":"L Dotevall","year":"1999","unstructured":"Dotevall, L., Hagberg, L., Karlsson, J. E. & Rosengren, L. E. Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in Lyme neuroborreliosis. Eur. J. Neurol. Off. J. Eur. Feder. Neurol. Soc. 6, 169\u2013178 (1999).","journal-title":"Eur. J. Neurol. Off. J. Eur. Feder. Neurol. Soc."},{"key":"79800_CR23","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s004150070134","volume":"247","author":"M Studahl","year":"2000","unstructured":"Studahl, M., Rosengren, L., Gunther, G. & Hagberg, L. Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction. J. Neurol. 247, 636\u2013642 (2000).","journal-title":"J. Neurol."},{"key":"79800_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/bf00427213","volume":"84","author":"Y Furuta","year":"1992","unstructured":"Furuta, Y. et al. Latent herpes simplex virus type 1 in human geniculate ganglia. Acta Neuropathol. 84, 39\u201344. https:\/\/doi.org\/10.1007\/bf00427213 (1992).","journal-title":"Acta Neuropathol."},{"key":"79800_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","volume":"99","author":"WA Eimer","year":"2018","unstructured":"Eimer, W. A. et al. Alzheimer\u2019s disease-associated beta-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron 99, 56\u201363. https:\/\/doi.org\/10.1016\/j.neuron.2018.06.030 (2018).","journal-title":"Neuron"},{"key":"79800_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3233\/JAD-2008-13405","volume":"13","author":"RF Itzhaki","year":"2008","unstructured":"Itzhaki, R. F. & Wozniak, M. A. Herpes simplex virus type 1 in Alzheimer\u2019s disease: the enemy within. J. Alzheimer\u2019s Dis. JAD 13, 393\u2013405 (2008).","journal-title":"J. Alzheimer's Dis. JAD"},{"key":"79800_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0022-510X(82)90183-6","volume":"54","author":"MM Esiri","year":"1982","unstructured":"Esiri, M. M. Herpes simplex encephalitis. An immunohistological study of the distribution of viral antigen within the brain. J. Neurol. Sci. 54, 209\u2013226 (1982).","journal-title":"J. Neurol. Sci."},{"key":"79800_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/joim.12190","volume":"275","author":"RC Petersen","year":"2014","unstructured":"Petersen, R. C. et al. Mild cognitive impairment: a concept in evolution. J. Intern. Med. 275, 214\u2013228. https:\/\/doi.org\/10.1111\/joim.12190 (2014).","journal-title":"J. Intern. Med."},{"key":"79800_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jama.2009.1064","volume":"302","author":"N Mattsson","year":"2009","unstructured":"Mattsson, N. et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA J. Am. Med. Assoc. 302, 385\u2013393. https:\/\/doi.org\/10.1001\/jama.2009.1064 (2009).","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"79800_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1474-4422(09)70134-6","volume":"8","author":"D Gilden","year":"2009","unstructured":"Gilden, D., Cohrs, R. J., Mahalingam, R. & Nagel, M. A. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 8, 731\u2013740. https:\/\/doi.org\/10.1016\/S1474-4422(09)70134-6 (2009).","journal-title":"Lancet Neurol."},{"key":"79800_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.cger.2013.07.002","volume":"29","author":"CN Harada","year":"2013","unstructured":"Harada, C. N., Natelson Love, M. C. & Triebel, K. L. Normal cognitive aging. Clin. Geriatr. Med. 29, 737\u2013752. https:\/\/doi.org\/10.1016\/j.cger.2013.07.002 (2013).","journal-title":"Clin. Geriatr. Med."},{"key":"79800_CR32","unstructured":"Conners CK, M. S. Conners' Continuous Performance Test II: Computer Program for Windows Technical Guide and Software Manual (Multi-Health Systems, 2000)."},{"key":"79800_CR33","unstructured":"D, W. Wechsler Memory Scale-Third Edition manual, Swedish version., (Harcourt Assessment, NCS Pearson Inc \/ Katarina Tryck AB, 2008)."},{"key":"79800_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0887-6177(03)00039-8","volume":"19","author":"TN Tombaugh","year":"2004","unstructured":"Tombaugh, T. N. Trail Making Test A and B: normative data stratified by age and education. Arch. Clin. Neuropsychol. 19, 203\u2013214. https:\/\/doi.org\/10.1016\/S0887-6177(03)00039-8 (2004).","journal-title":"Arch. Clin. Neuropsychol."},{"key":"79800_CR35","unstructured":"Delis DC, K. J., Kaplan E, Ober BA. California Verbal Learning Test - second edition. Adult version. Manual (Psychological Corporation, 2000)."},{"key":"79800_CR36","unstructured":"RHB, B. Brief visuospatial memory test - revised: Professional manual (Psychological Assessment Resources, Inc, 1997)."},{"key":"79800_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.acn.2005.07.003","volume":"21","author":"LK Sheridan","year":"2006","unstructured":"Sheridan, L. K. et al. Normative symbol digit modalities test performance in a community-based sample. Arch. Clin. Neuropsychol. 21, 23\u201328. https:\/\/doi.org\/10.1016\/j.acn.2005.07.003 (2006).","journal-title":"Arch. Clin. Neuropsychol."},{"key":"79800_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bandl.2004.11.004","volume":"94","author":"IM Tallberg","year":"2005","unstructured":"Tallberg, I. M. The Boston naming test in Swedish: normative data. Brain Lang. 94, 19\u201331. https:\/\/doi.org\/10.1016\/j.bandl.2004.11.004 (2005).","journal-title":"Brain Lang."},{"key":"79800_CR39","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1467-9450.2008.00653.x","volume":"49","author":"IM Tallberg","year":"2008","unstructured":"Tallberg, I. M., Ivachova, E., Jones Tinghag, K. & Ostberg, P. Swedish norms for word fluency tests: FAS, animals and verbs. Scand. J. Psychol. 49, 479\u2013485. https:\/\/doi.org\/10.1111\/j.1467-9450.2008.00653.x (2008).","journal-title":"Scand. J. Psychol."},{"key":"79800_CR40","unstructured":"Warrington EK, J. A. The Visual Object and Space Perception Battery. . (Thames Valley Test Company, 1991)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79800-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79800-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79800-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:12:17Z","timestamp":1670357537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79800-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,28]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["79800"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-79800-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,28]]},"assertion":[{"value":"14 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HZ has served at scientific advisory boards for Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics and CogRx, has given lectures in symposia sponsored by Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). The other authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22400"}}